tirzepatide updates appears to be more effective than standard care in early type 2 diabetes Tirzepatide Week 15 Update |

PMCID: PMC3827015

They will guide you on how often you should receive the injections based on your unique goals and overall health

This leads to gradual skin darkening over time, mimicking the effects of a sun-induced tan without significant UV exposure

JFDA 22:296302

Both Are Excellent Choices: You cant make a wrong decision between these two medications

Automated Insulin Delivery ADA Only The ADA made sweeping changes to AID recommendations in 2026: AID is now the preferred insulin delivery method for all people with type 1 diabetes AID is preferred for adults and children with T2D on multiple daily injections, CSII, or sensor-augmented pump therapy AID should be offered to all adults with T1D or T2D on insulin AID can be considered in T2D on basal insulin who are not meeting glycemic goals No C-peptide level, islet autoantibody status, or insulin duration is required before starting CSII or AID Children and adolescents must be supported in device use at school